AGP Executive Report
Last update: 3 hours agoMedical access & costs: Consumer Reports and KFF highlight common U.S. billing “traps” that surprise insured patients—like out-of-network clinicians you didn’t choose and bills arriving before insurance finishes—plus practical steps to spot errors and dispute them. Safe use of popular drugs: The NHS warns people taking atorvastatin to be careful with other medicines and supplements due to “serious” side-effect risks. GLP-1s online: A guide urges shoppers to vet online GLP-1 sellers and prescribers with key questions before buying. Knee pain treatment: A non-surgical procedure using genicular artery embolization is reported to halve knee osteoarthritis pain over a 12-month trial. Medicare planning: A finance explainer stresses that Roth conversions can trigger Medicare premium surcharges if done after the age-62 conversion window closes. India health system fixes: Kerala begins ending floor admissions in government medical colleges to reduce overcrowding. Education & training: MARA may sponsor an underprivileged Malaysian student’s medicine path; NMC also pushes medical colleges to patent innovations via an ICMR-backed program. Pharma regulation: NPPA issues a demand notice alleging GSK overcharged scheduled formulations; UPSC invites applications for 186 CDSCO drug inspector posts. Global healthcare partnerships: UDST signs an MoU with Qatar Armed Forces Medical Services to expand training and research.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.